SCHEMBL19168474

SCHEMBL19168474

c1ccc(-c2nc(-c3ccc(-c4ccc(-c5ccc6ccc7cccc8ccc5c6c78)cc4)cc3)cc(-c3ccccc3-c3ccccn3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.39
TSHR P16473 3/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 7/20 0.39
MAPT P10636 7/20 0.39
HPGD P15428 6/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
NTSR1 P30989 1/20 0.39
KDM4E B2RXH2 6/20 0.38
LMNA P02545 4/20 0.38
GLA P06280 1/20 0.38
MAOB P27338 4/20 0.37
MAOA P21397 2/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
TP53 P04637 3/20 0.37
RAB9A P51151 2/20 0.37
PKM P14618 2/20 0.37
KLF5 Q13887 2/20 0.37
TOP1 P11387 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19168071 0.99 HSD17B10 (0.40) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19167665 0.99 HSD17B10 (0.40) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19168482 0.94 HPGD (0.41) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19167342 0.93 HSD17B10 (0.43) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19168095 0.93 HPGD (0.42) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19167002 0.93 HPGD (0.42) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19167646 0.93 HPGD (0.42) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19167156 0.92 HPGD (0.41) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL19168113 0.91 HPGD (0.42) HSD17B10TSHRMAPK1ALDH1A1MAPT
SCHEMBL17013864 0.91 MAPK1 (0.40) HSD17B10TSHRMAPK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 US disclosed
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, RBM12, H1-2 HSD17B10 2839/4885TSHR 1590/4885MAPK1 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.